AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
29 Jan 2003 09:00 AM
RNS
Notice of Results
14 Jan 2003 04:00 PM
RNS
Capital Group
10 Jan 2003 03:00 PM
RNS
Capital Group
09 Jan 2003 03:00 PM
RNS
Update on Iressa
02 Jan 2003 01:30 PM
RNS
Seroquel
23 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
20 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
19 Dec 2002 07:09 AM
RNS
Casodex
19 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
16 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
13 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
12 Dec 2002 10:00 AM
RNS
Omeprazole Judgment
12 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
11 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
06 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
05 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
04 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
02 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
29 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
28 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
27 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
26 Nov 2002 04:07 PM
RNS
Director Shareholding
26 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
25 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
22 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
21 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
18 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
15 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
14 Nov 2002 03:00 PM
RNS
Directorate Change
14 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
13 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
11 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
07 Nov 2002 08:30 AM
RNS
Annual Review
07 Nov 2002 07:00 AM
RNS
Crestor
05 Nov 2002 01:00 PM
RNS
Omeprazole Judgment Appeal
28 Oct 2002 07:00 AM
RNS
Exanta Express
24 Oct 2002 11:00 AM
RNS
3rd Quarter Results-Part 2
24 Oct 2002 11:00 AM
RNS
3rd Quarter Results-Part 1
23 Oct 2002 09:00 AM
RNS
Notice of Results
22 Oct 2002 11:49 AM
RNS
Omeprazole Patent Ruling
14 Oct 2002 07:06 AM
RNS
Prilosec Patents Ruling
30 Sep 2002 04:00 PM
RNS
Holding(s) in Company
25 Sep 2002 07:01 AM
RNS
Iressa
16 Sep 2002 07:00 AM
RNS
Symbicort
12 Sep 2002 07:00 AM
RNS
Purchase of Own Securities
11 Sep 2002 03:00 PM
RNS
Capital Group
11 Sep 2002 07:00 AM
RNS
Purchase of Own Securities
10 Sep 2002 07:00 AM
RNS
Purchase of Own Securities
06 Sep 2002 07:00 AM
RNS
Arimidex
06 Sep 2002 07:00 AM
RNS
Purchase of Own Securities
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100

Latest directors dealings